Get The Spin Brief
CRISPRMRIimmunotherapyclinical trialorganoidsbiological age
Healthspan, honestly

Longevity

Aging biology, healthspan, clinical evidence and interventions under study — with an honest line between hype and evidence.

Aging & age-related diseaseAging interventionsBiomarkers & diagnosticsCell biologyEpigeneticsMedical devices & sensors
Abstract editorial illustration of a dashboard of glowing gauges and line traces, some sharp and solid, others faint and dotted, representing established and experimental health measures.
LongevityEvidence: Mixed / overview
Featured story

The Longevity Dashboard: Which Health Measures Are Useful, and Which Are Still Experimental?

From blood-pressure cuffs to epigenetic clocks, people now track dozens of numbers hoping to live longer. A field guide to which measures have the evidence behind them.

The Spin
01Consumers can now track many health numbers, from blood pressure and glucose sensors to DNA-methylation 'biological age' tests. The evidence behind these…
02Blood pressure, cholesterol, blood sugar and activity have strong evidence and established actions. Grip strength predicts mortality in large observational studies. Epigenetic…
03Whether acting on biological-age scores, or tracking glucose in people without diabetes, improves long-term health has not been shown.

Latest in Longevity

Hype vs. evidence

Abstract editorial illustration of a winding path through a landscape of data points, some bright and solid, others hazy, suggesting strong and weak evidence.
LongevityEvidence: Mixed / overview
Hype vs. evidence

Can We Slow Aging? A Field Guide to Evidence, Hype, and Hard Questions

Rapamycin, metformin, NAD+ boosters, senolytics, calorie restriction and young plasma: what the evidence actually shows, and what remains unknown.

The Spin
01A crowded market of longevity drugs, supplements and clinics promises to slow ageing, drawing on real but mostly early science.
02Rapamycin extended lifespan in mice; calorie restriction improved some risk factors in a two-year human trial; NAD+ precursors raise NAD+ levels but…
03Whether any drug or supplement slows human ageing, how to measure biological ageing reliably, and the long-term safety of interventions in healthy…

From The Lab

Enter The Lab
Curated · attributed · embed-permitted

Watch and learn

Video library
Science communicator

Why Age? Should We End Aging Forever?

An animated explanation of the cellular processes thought to drive aging, including DNA damage, telomere shortening and senescent cells. It also looks at the…

Video · Kurzgesagt – In a Nutshell
Keep exploring

Explore other frontiers

BreakthroughsSignificant discoveries, therapy advances and trial results — with every early-stage finding…AI + MedicineDrug discovery, diagnostics, AI-assisted MRI and imaging, clinical trials, robotics, wearables and…Companies + StocksPublic companies and startups, pipelines, partnerships, funding and milestones — scientific progress…DeepTech + MedTechImaging, surgical technology, sensors, lab automation, organoids, bioprinting, brain health and next-generation…Genome + CellsSequencing, gene editing, gene therapy, epigenetics, cell therapies — and what genomic…Cancer FrontiersTreatments by mechanism, early detection, precision oncology, immunotherapy and prevention research. Cancer…The LabWhat-if thought experiments, clearly labelled.Play + LearnGames, quizzes and visual explainers.ResourcesInstitutions, databases, trials and a glossary.
Weekly newsletter

The Spin Brief

One concise weekly roundup of what moved in medicine — what happened, what the evidence shows, and what to watch next. No hype, no stock tips.

  • Five stories that mattered, each with its own Spin
  • One stage change in the pipeline tracker, sourced
  • One Lab question to think about

We use double opt-in: check your inbox to confirm. We never sell your address, and we never ask for health or genetic information.